Abstract
Weight loss in response to the long-acting GLP-1 receptor (GLP1R) analog, liraglutide, is correlated with delay in gastric-emptying (GE). The aim of this pilot study was to assess whether specific genetic variants in GLP1R or TCF7L2 are associated with delayed GE and weight loss in obese patients treated with liraglutide or the short-acting GLP-1 agonist, exenatide. We evaluated in obese individuals the associations of genetic variations of GLP1R (rs6923761) and TCF7L2 (rs7903146) on GE T1/2 and weight from two trials that evaluated separately exenatide, 5 μg BID for 30 days, or liraglutide, 3 mg daily for 5 weeks. Data were analyzed using the dominant genetic model and intention-to-treat analysis. There was a significant correlation between changes in weight and GE T1/2 (rs = -.382, P = .004). GLP1R rs6923761 minor allele A (AA_AG) carriers who received either exenatide or liraglutide had greater delay in GE T1/2 relative to baseline (117.9 ± 27.5 [SEM] minutes and 128.9 ± 38.32 minutes) compared to GG genotype (95.8 ± 30.4 minutes and 61.4 ± 21.4 minutes, respectively; P = .11). There was a non-significant difference in weight loss based on GLP1R rs6923761 genotype after 5 weeks of treatment. There were no significant correl...Continue Reading
References
Dec 31, 1997·The American Journal of Physiology·M A NauckW H Schmiegel
May 20, 1998·Digestive Diseases and Sciences·E NäslundP M Hellström
Sep 25, 2002·Alimentary Pharmacology & Therapeutics·F CremoniniM R Rank
Nov 8, 2006·Gastroenterology·Maria I Vazquez RoqueAlan R Zinsmeister
Mar 17, 2009·Diabetologia·K PilgaardA A Vaag
Nov 7, 2009·The Journal of Clinical Endocrinology and Metabolism·Adam M DeaneMichael Horowitz
Nov 26, 2009·Diabetes·Dennis T VillarealKenneth S Polonsky
May 29, 2010·Diabetes·Filip K Knop
Sep 2, 2010·Diabetes Care·Airani SathananthanAdrian Vella
Jun 16, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·A PapadopoulouUNKNOWN DiPiS Study Group
Jun 29, 2011·Clinical and Translational Science·Maria I Vazquez-RoqueAlan R Zinsmeister
Jul 4, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M CamilleriA R Zinsmeister
Dec 6, 2012·American Journal of Physiology. Endocrinology and Metabolism·Radhika V SeimonChristine Feinle-Bisset
Jun 29, 2014·Journal of Endocrinological Investigation·Daniel Antonio de LuisG Diaz Soto
Dec 9, 2014·Gastroenterology·Andres AcostaAlan R Zinsmeister
Apr 1, 2015·Journal of Diabetes and Its Complications·Daniel Antonio de LuisEnrique Romero
May 21, 2015·European Journal of Clinical Pharmacology·Mojca JensterleAndrej Janež
May 28, 2015·Journal of Endocrinological Investigation·D A de LuisE Romero
Jul 3, 2015·The New England Journal of Medicine·Xavier Pi-SunyerUNKNOWN SCALE Obesity and Prediabetes NN8022-1839 Study Group
Nov 7, 2015·Physiological Reports·Andres AcostaAlan R Zinsmeister
Nov 17, 2015·The Journal of Clinical Investigation·Makoto ShigetoPatrik Rorsman
Aug 5, 2017·American Journal of Physiology. Gastrointestinal and Liver Physiology·Houssam HalawiAlan R Zinsmeister
Sep 30, 2017·The Lancet. Gastroenterology & Hepatology·Houssam HalawiMichael Camilleri
Citations
Apr 21, 2020·Pharmacogenomics·Anna ŰrgeováAlena Stančáková Yaluri
Mar 25, 2019·Journal of Clinical Medicine·Chan Uk Heo, Chang-Ik Choi
Sep 24, 2020·International Journal of Molecular Sciences·Yulia A NasykhovaAndrey S Glotov
Sep 16, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Zhiwei ZengTao Sun
May 30, 2019·BMJ Open Gastroenterology·Eric J VargasBarham K Abu Dayyeh
Oct 2, 2020·Diabetes, Obesity & Metabolism·Mona MashayekhiNancy J Brown
Aug 26, 2019·Journal of Molecular Biology·Alejandra TomasColin Leech
Jan 26, 2021·Obesity·Sneha SinghAndres Acosta
Jan 29, 2021·Nutrients·Joanna MichałowskaPaweł Bogdański
May 1, 2021·Nutrients·Lizeth CifuentesAndres Acosta
Aug 10, 2021·Diabetes & Metabolic Syndrome·Zhichun Guo, Ronny Priefer